The impact of consolidation on the medtech industry
A panel of CEOs, medical device manufacturers (OEMs), and private equity investors discuss the impact consolidation is having on the supply chain in medtech.
12/02/2019
Livingstone curated a panel of CEOs, medical device manufacturers (OEMs), and private equity investors to discuss key drivers of the medtech M&A boom.
Karl Freimuth, partner and co-head of the US industrials practice at Livingstone moderated the discussion. Panelists included:
- Kevin Cordero, Stryker Craniomaxillofacial, Director, Clinical Research & Market Intelligence
- Hunter Craig, GTCR, Vice President
- Steve Sundberg, MedTorque, President & CEO
- Chris Witham, Motion Dynamics, CEO
A key driver of the boom was identified, and discussed, by the panelists was the overall impact consolidation has on the supply chain within medtech.
Share on: